Status:
UNKNOWN
RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19
Lead Sponsor:
Versailles Hospital
Conditions:
SARS-CoV Infection
Pinkeye
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
the purpose of the study is to study the detection of SARS-Cov-2 virus in the conjunctiva of covid-19 patients and the presence or absence of conjunctivitis in these patients
Eligibility Criteria
Inclusion
- Men and Women positive for SARS-Cov-2 on a RT-PCR test of a sample of respiratory airway
- Persons over 18 years of age
- patients of both sexes
- Member of a social security scheme
- Having signed the consent form
Exclusion
- Minors not emancipated, persons out of state to express their consent
- Participation in intervention research on Covid-19 involving experimental treatment
- History of chronic disease conjunctiva
- Patient with one of the one of the criteria of following gravity:
- EN \> or =30/min,
- Pao2/Fio2 = or \< 300,
- confusion and/or disorientation,
- hypotension (Tas90mmhg, requiring aggressive filling),
- need for a invasive ventilation,
- septic shock
Key Trial Info
Start Date :
May 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 15 2021
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT04397666
Start Date
May 15 2020
End Date
December 15 2021
Last Update
August 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de versailles
Le Chesnay, France, 78390